Search Page

1

Cite

Share

Cell therapy for lung disease.

Geiger S, Hirsch D, Hermann FG. Geiger S, et al. Among authors: hermann fg. Eur Respir Rev. 2017 Jun 28;26(144):170044. doi: 10.1183/16000617.0044-2017. Print 2017 Jun 30. Eur Respir Rev. 2017. PMID: 28659506 Free article. Review.

Cite

Share

2

Cite

Share

Local Intracerebral Immunomodulation Using Interleukin-Expressing Mesenchymal Stem Cells in Glioblastoma.

Mohme M, Maire CL, Geumann U, Schliffke S, Dührsen L, Fita K, Akyüz N, Binder M, Westphal M, Guenther C, Lamszus K, Hermann FG, Schmidt NO. Mohme M, et al. Among authors: hermann fg. Clin Cancer Res. 2020 Jun 1;26(11):2626-2639. doi: 10.1158/1078-0432.CCR-19-0803. Epub 2020 Jan 27. Clin Cancer Res. 2020. PMID: 31988196

Cite

Share

3

Cite

Share

IL7-IL12 Engineered Mesenchymal Stem Cells (MSCs) Improve A CAR T Cell Attack Against Colorectal Cancer Cells.

Hombach AA, Geumann U, Günther C, Hermann FG, Abken H. Hombach AA, et al. Among authors: hermann fg. Cells. 2020 Apr 3;9(4):873. doi: 10.3390/cells9040873. Cells. 2020. PMID: 32260097 Free PMC article.

Cite

Share

4

Cite

Share

Alpha-1 Antitrypsin-Expressing Mesenchymal Stromal Cells Confer a Long-Term Survival Benefit in a Mouse Model of Lethal GvHD.

Geiger S, Ozay EI, Geumann U, Hereth MK, Magnusson T, Shanthalingam S, Hirsch D, Kälin S, Günther C, Osborne BA, Tew GN, Hermann FG, Minter LM. Geiger S, et al. Among authors: hermann fg. Mol Ther. 2019 Aug 7;27(8):1436-1451. doi: 10.1016/j.ymthe.2019.05.007. Epub 2019 May 16. Mol Ther. 2019. PMID: 31138510 Free PMC article.

Cite

Share

5

Cite

Share

Preclinical analysis of human mesenchymal stem cells: tumor tropism and therapeutic efficiency of local HSV-TK suicide gene therapy in glioblastoma.

Dührsen L, Hartfuß S, Hirsch D, Geiger S, Maire CL, Sedlacik J, Guenther C, Westphal M, Lamszus K, Hermann FG, Schmidt NO. Dührsen L, et al. Among authors: hermann fg. Oncotarget. 2019 Oct 22;10(58):6049-6061. doi: 10.18632/oncotarget.27071. eCollection 2019 Oct 22. Oncotarget. 2019. PMID: 31692882 Free PMC article.

Cite

Share

6

Cite

Share

Secreted antiviral entry inhibitory (SAVE) peptides for gene therapy of HIV infection.

Egerer L, Volk A, Kahle J, Kimpel J, Brauer F, Hermann FG, von Laer D. Egerer L, et al. Among authors: hermann fg. Mol Ther. 2011 Jul;19(7):1236-44. doi: 10.1038/mt.2011.30. Epub 2011 Mar 1. Mol Ther. 2011. PMID: 21364540 Free PMC article.

Cite

Share

7

Cite

Share

Protein scaffold and expression level determine antiviral activity of membrane-anchored antiviral peptides.

Hermann FG, Martinius H, Egelhofer M, Giroglou T, Tonn T, Roth SD, Zahn R, Schult-Dietrich P, Alexandrov A, Dietrich U, Baum C, von Laer D. Hermann FG, et al. Hum Gene Ther. 2009 Apr;20(4):325-36. doi: 10.1089/hum.2006.158. Hum Gene Ther. 2009. PMID: 19267665

Cite

Share

8

Cite

Share

Towards hematopoietic stem cell-mediated protection against infection with human immunodeficiency virus.

Schambach A, Schiedlmeier B, Kühlcke K, Verstegen M, Margison GP, Li Z, Kamino K, Bohne J, Alexandrov A, Hermann FG, von Laer D, Baum C. Schambach A, et al. Among authors: hermann fg. Gene Ther. 2006 Jul;13(13):1037-47. doi: 10.1038/sj.gt.3302755. Epub 2006 Mar 16. Gene Ther. 2006. PMID: 16541120

Cite

Share

9

Cite

Share

Efficient entry inhibition of human and nonhuman primate immunodeficiency virus by cell surface-expressed gp41-derived peptides.

Zahn RC, Hermann FG, Kim EY, Rett MD, Wolinsky SM, Johnson RP, Villinger F, von Laer D, Schmitz JE. Zahn RC, et al. Among authors: hermann fg. Gene Ther. 2008 Sep;15(17):1210-22. doi: 10.1038/gt.2008.73. Epub 2008 May 1. Gene Ther. 2008. PMID: 18449216 Free PMC article.

Cite

Share

10

Cite

Share

Mutations in gp120 contribute to the resistance of human immunodeficiency virus type 1 to membrane-anchored C-peptide maC46.

Hermann FG, Egerer L, Brauer F, Gerum C, Schwalbe H, Dietrich U, von Laer D. Hermann FG, et al. J Virol. 2009 May;83(10):4844-53. doi: 10.1128/JVI.00666-08. Epub 2009 Mar 11. J Virol. 2009. PMID: 19279116 Free PMC article.

Cite

Share